This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Urologix Announces Presentation Of Clinical Data At Geriatric Urological Society During AUA 2010 Annual Meeting

Urologix®, Inc. (NASDAQ: ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), announced the selection of two clinical abstracts for podium presentation at the American Urological Association (AUA) 2010 Annual Meeting’s sub-specialty society, the Geriatric Urological Society (GUS) meeting, to be held at the Marriot Nob Hill in San Francisco on Sunday, May 30, 2010 from 3:00pm to 5:00pm PDT.

“We are pleased the Geriatric Urological Society selected ‘Sexual Function after Cooled High Energy Transurethral Thermotherapy: Results of Patient Clinical Data up to 5 Years Post-Treatment’ and ‘Intra-Prostatic Temperatures and Necrosis during High Energy Cooled Microwave Treatment’ for presentation,” said Stryker Warren jr., Chief Executive Officer. “Urologix has led the minimally invasive space for the treatment of BPH when one inventories the clinical studies and the resultant publications and presentations. This speaks to both the efficacy of our technology and our commitment to the science of high energy, cooled microwave therapy. We are gratified by the interest again this year in clinical abstracts which advance the knowledge and the comparative effectiveness of high energy, Cooled ThermoTherapy™ which is the province of Urologix.”

Thayne Larson, MD will present the two abstracts in a podium session. Dr. Larson is one of the early participants in clinical trials with Urologix in 1991; he practiced at the Mayo Clinic, Scottsdale, AZ and now is an independent researcher at The Institute of Medical Research, Scottsdale, AZ.

Urologix is an exhibitor at the AUA 2010 Annual Meeting at the Moscone Center in San Francisco from May 29 through June 1, 2010. The exhibit will emphasize the advantages of Cooled ThermoTherapy™ versus BPH drugs while also demonstrating the distinct difference in peer reviewed published data available to support cooled high-energy transurethral microwave therapy versus low energy alternatives.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ULGX $0.08 -5.86%
AAPL $126.41 -1.66%
FB $81.21 0.39%
GOOG $575.33 0.34%
TSLA $200.63 -0.89%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs